Search for Jean-Pierre Garnier and
  1. July 6, 2012

    GSK ills symptomatic of wider malaise

    More than a year after Andrew Witty was selected to run GlaxoSmithKline, the executive director of marketing for its biggest...

  2. May 11, 2012

    Witty targets HGS with first hostile bid

    Henry Wellcome, the US immigrant who laid the foundations 130 years ago for the UK-based pharmaceutical group...

  1. October 20, 2011

    Actelion shares tumble over quarterly results

    Actelion, Europe’s biggest biotechnology group by sales, saw its shares fall sharply on Thursday as third-quarter results...

  2. May 5, 2011

    Actelion fends off Elliott Advisors

    Rebel shareholders’ efforts to overturn the incumbent management of Actelion at the annual general meeting of the Swiss...

  3. May 4, 2011

    Garnier defends Actelion against rebels

    Jean-Pierre Garnier, the senior pharmaceutical executive up for election on Thursday as chairman of Actelion, has launched a...

  4. April 14, 2011

    Elliott keeps up pressure on Actelion

    Rebel investors stepped up their criticism of Actelion on Thursday as they pursued efforts to appoint new board members to...

  5. FT Alphaville

    April 6, 2011

    Snap news

    Breaking pre-market news on Wednesday, - Commerzbank to raise €11bn via mandatory convertible notes and rights issue –...

  6. April 6, 2011

    Actelion chooses Garnier as next chairman

    Actelion has beefed up its defences in its battle with US activist investor Elliott Advisors with the surprise nomination of...

  7. December 14, 2009

    The careerist: Replacing a hero: how to succeed the boss from heaven

    Any promotion forces you to redouble your efforts to impress, and this is especially true when your predecessor was...

  8. December 13, 2009

    The careerist: Replacing a hero

    Any promotion forces you to redouble your efforts to impress, and this is especially true when your predecessor was...

  9. December 1, 2009

    DIC's business grandees

    With the Dubai brand hit hard by last week's events, investment group Dubai International Capital's chairman Sameer Al...

  10. November 3, 2009

    Shire hires GSK contender

    As GlaxoSmithKline boss Andrew Witty celebrates his second anniversary at the helm of the pharma group, one of his former...

  11. May 21, 2009

    Dogged in pursuit of the fat-cats

    When the cultivated Scottish voice of Guy Jubb meted out his objections to the pay report at the Shell meeting in The Hague...

  12. May 21, 2009

    Glaxo patient under monitoring

    Avoiding undue pressure on the pulse-point over pay, GlaxoSmithKline chairman Sir Christopher Gent and pay committee boss...

  13. May 20, 2009

    Investors take aim after Shell takes them for granted

    John Kerr wasn't offered a final cigarette, but there was a moment yesterday when the former diplomat, chainsmoker and...

  14. May 19, 2009

    Investors take aim after Shell takes them for granted

    John Kerr wasn’t offered a final cigarette, but there was a moment on Tuesday when the former diplomat, chainsmoker and...

  15. May 11, 2009

    GSK investors urged to reject Garnier package

    A leading investor watchdog has called on shareholders to reject a performance-related share package for Jean-Pierre...

  16. May 10, 2009

    GSK investors urged to reject Garnier package

    A leading investor watchdog has called on shareholders to reject a performance-related share package for Jean-Pierre...

  17. February 16, 2009

    A holistic approach to leadership

    He speaks with a hint of the accent of his native Germany, mixed with the twang of the English of Canada where he grew up....

  18. February 15, 2009

    A holistic approach

    He speaks with a hint of the accent of his native Germany, mixed with the twang of the English of Canada where he grew up....

  19. February 2, 2009

    An acute talent for innovation

    Sir James Black places his walking stick on one side, eases himself into a plump yellow sofa at the Royal Society of...

  20. February 1, 2009

    An acute talent for innovation

    Sir James Black places his walking stick on one side, eases himself into a plump yellow sofa at the Royal Society of...

  21. October 21, 2008

    As supply of execs rises, price must fall

    From Mr George Collie. Sir, Parts of your report on corporate incentives (“Shareholders and boards in bonus face-off”,...

  22. October 7, 2008

    Dose of change for a struggling sector

    The decision by the board of Sanofi-Aventis of France last month to oust its chief executive and replace him with not only...

  23. October 6, 2008

    Medicine for a sector

    The decision by the board of Sanofi-Aventis of France last month to oust its chief executive and replace him with not only...

  24. September 10, 2008

    GSK's Viehbacher to join Sanofi-Aventis

    Chris Viehbacher, head of GlaxoSmithKline's North American pharmaceutical operations, is poised to join Sanofi-Aventis as a...

  25. September 9, 2008

    GSK executive quits to lead rival

    Chris Viehbacher, one of the most senior executives at GlaxoSmithKline, the pharmaceuticals group, is to quit for a top job...

  26. September 9, 2008

    Bonus of contention

    GlaxoSmithKline endured shareholder discontent to push through a "retention bonus" for Chris Viehbacher, a loser in the...

  27. September 9, 2008

    GSK executive's exit heralds drug sector shake-up

    Chris Viehbacher, one of the most senior executives at GlaxoSmithKline, the UK pharmaceuticals group, is to quit for a top...

  28. September 9, 2008

    GSK executive quits to lead rival

    Chris Viehbacher, one of the most senior executives at GlaxoSmithKline, the pharmaceuticals group, is to quit for a top job...

  29. August 29, 2008

    JPG returns to his French roots

    After suffering Napoleonic jibes during his time, Jean-Pierre Garnier , the former head of GlaxoSmithKline, the UK-based...

  30. July 24, 2008

    FTSE 100 CEOs

    Andrew Witty, the 43-year-old who yesterday made his first results presentation as the new boss of GSK, makes for a rather...

  31. July 23, 2008

    FTSE100 CEOs

    Andrew Witty, the 43-year-old who on Wednesday made his first results presentation as the new boss of GSK, makes for a...

  32. May 24, 2008

    The Week

    Shareholders are revolting - as company directors are learning to their cost, or at least embarrassment. As the Bank of...

  33. May 22, 2008

    JP Garnier takes his medicine

    Glasses perched on the edge of his nose, Jean-Pierre Garnier was quietly forceful in defence of the strategy of the drugs...

  34. May 21, 2008

    GSK faces revolt over retention bonus

    GlaxoSmithKline has become the latest company to face a shareholder revolt over bonus payments to retain an executive in a...

  35. May 19, 2008

    GSK chief leaves a mixed prognosis

    Jean-Pierre Garnier, the first chief executive of GlaxoSmithKline, the UK-based pharmaceuticals company created through a...

  36. May 17, 2008

    Hikma threatens to move domicile if tax rules change

    The chief executive of Hikma, the UK-quoted generic medicines company, yesterday joined ranks with other groups that have...

  37. May 16, 2008

    Tough US drugs bar to remain,says GSK

    US regulators have permanently raised the bar for approving new medicines in a way that will force companies to change how...

  38. May 15, 2008

    GSK sees tough US regulation

    US regulators have permanently raised the bar for approving new medicines in a way that will force companies to change how...

Search for Jean-Pierre Garnier and